IEX

IDEX Corporation 2007 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: IDEX Corporation (IDEX)
Reporting Period: Fiscal year ended December 31, 2007
Business Overview: IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety, and diversified products. The company operates through four reportable segments and serves a diverse range of global industries including industrial infrastructure, life sciences, and fire/rescue. As of December 31, 2007, the company employed 5,009 people.

Key Financial Metrics

Margins: Gross margin improved to 41.8% (up 50 bps); Operating margin remained flat at 18.8%.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 18% to $1.36 billion. Organic sales growth was 6%, while acquisitions contributed 9% and foreign currency translation contributed 3%.
• Profitability: Income from continuing operations rose 17% to $155.9 million. Net income increased 6% to $155.1 million.
• Acquisitions: Significant growth was driven by seven acquisitions since early 2006, including Faure Herman, Quadro, and Isolation Technologies in 2007. The Fluid & Metering Technologies segment saw the largest sales increase (31%) due to acquisitions and organic growth.
• Discontinued Operations: The company sold its Halox business in 2007, resulting in a $0.7 million loss from discontinued operations, compared to a $12.9 million gain in 2006 (driven by the sale of Lubriquip).
• Debt Levels: Total borrowings increased to $454.7 million from $362.0 million, primarily to finance acquisitions. Interest expense rose to $23.4 million from $16.4 million.

Guidance, Outlook, and Risks

2008 Outlook:

• Fluid & Metering: Expected to be driven by global infrastructure investment and process control demand.
• Health & Science: Strength in analytical instrumentation and biotech expected to offset residual effects of maturing OEM contracts.
• Dispensing Equipment: Growth anticipated from U.S. retailer replenishment and global paint channel expansion, partially offset by North American housing market softness.
• Fire & Safety: Continued performance driven by band clamping innovation and rescue tools, offset by weakness in North American fire suppression.

Key Risks and Contingencies:

• Foreign Currency: 46% of sales are international; significant fluctuations in the Euro, British Pound, or Canadian Dollar could materially impact results.
• Interest Rates: Approximately 67% of debt is floating rate. A 50-basis point increase would raise annual interest expense by ~$1.5 million.
• Acquisition Integration: Future growth relies on successful identification and integration of acquisitions, which carries execution risk.
• Legal Proceedings: The company faces asbestos-related litigation, though management does not currently believe these will have a material adverse effect.

Investor Verification Checklist

• Acquisition Synergies: Verify the integration progress and revenue contribution of 2007 acquisitions (Quadro, Faure Herman, Isolation Technologies) and the subsequent ADS acquisition (completed Jan 2008).
• Debt Servicing: Confirm compliance with credit facility covenants (minimum interest coverage ratio of 3.0:1 and maximum leverage ratio of 3.25:1) given the increased debt load.
• Organic Growth Sustainability: Assess whether the 6% organic growth rate is sustainable without further M&A, particularly in the Health & Science segment where specific OEM contracts are maturing.
• Discontinued Operations: Review the final financial impact of the Halox and Lubriquip divestitures to ensure no lingering liabilities.
• Foreign Exchange Exposure: Monitor currency hedging strategies given that nearly half of revenue is generated outside the U.S.